Akcea Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 294

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Akcea Therapeutics General Information

Description

Akcea Therapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. It is advancing a mature pipeline of novel drugs with the potential to treat multiple diseases. The company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense technology developed by Ionis Pharmaceuticals, Inc. Its most advanced drug, volanesorsen, has completed a Phase 3 clinical program for the treatment of familial chylomicronemia syndrome, or FCS, and is currently in Phase 3 clinical development for the treatment of familial partial lipodystrophy, or FPL.

Contact Information

Website
www.akceatx.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 22 Boston Wharf Road
  • 9th Floor
  • Boston, MA 02210
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 22 Boston Wharf Road
  • 9th Floor
  • Boston, MA 02210
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Akcea Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Akcea Therapeutics‘s full profile, request access.

Request a free trial

Akcea Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Akcea Therapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing drugs t
Drug Discovery
Boston, MA
294 As of 2019

Morristown, NJ
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Akcea Therapeutics Competitors (21)

One of Akcea Therapeutics’s 21 competitors is Intercept Pharmaceuticals, a Formerly VC-backed company based in Morristown, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Intercept Pharmaceuticals Formerly VC-backed Morristown, NJ
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
Gilead Formerly VC-backed Foster City, CA
Cirius Therapeutics Venture Capital-Backed Grand Rapids, MI
Protalix Biotherapeutics Formerly VC-backed Karmiel, Israel
You’re viewing 5 of 21 competitors. Get the full list »

Akcea Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akcea Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Akcea Therapeutics‘s full profile, request access.

Request a free trial

Akcea Therapeutics FAQs

  • When was Akcea Therapeutics founded?

    Akcea Therapeutics was founded in 2014.

  • Where is Akcea Therapeutics headquartered?

    Akcea Therapeutics is headquartered in Boston, MA.

  • What is the size of Akcea Therapeutics?

    Akcea Therapeutics has 294 total employees.

  • What industry is Akcea Therapeutics in?

    Akcea Therapeutics’s primary industry is Drug Discovery.

  • Is Akcea Therapeutics a private or public company?

    Akcea Therapeutics is a Private company.

  • What is the current valuation of Akcea Therapeutics?

    The current valuation of Akcea Therapeutics is .

  • What is Akcea Therapeutics’s current revenue?

    The current revenue for Akcea Therapeutics is .

  • How much funding has Akcea Therapeutics raised over time?

    Akcea Therapeutics has raised $175M.

  • Who are Akcea Therapeutics’s investors?

    Novartis has invested in Akcea Therapeutics.

  • Who are Akcea Therapeutics’s competitors?

    Intercept Pharmaceuticals, Alnylam Pharmaceuticals, Gilead, Cirius Therapeutics, and Protalix Biotherapeutics are some of the 21 competitors of Akcea Therapeutics.

  • When was Akcea Therapeutics acquired?

    Akcea Therapeutics was acquired on 12-Oct-2020.

  • Who acquired Akcea Therapeutics?

    Akcea Therapeutics was acquired by Ionis Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process